|
Volumn 16, Issue 12, 2000, Pages 1483-1487
|
The burden of blood pressure: Where are we and where should we go?;Le fardeau de l'hypertension: Le point et l'avenir
|
Author keywords
Blood pressure; Hypertension
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
ANGIOTENSIN II ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
PERINDOPRIL;
BLOOD PRESSURE MONITORING;
BLOOD PRESSURE REGULATION;
CANADA;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
DEATH;
DRUG MECHANISM;
EPIDEMIC;
FATALITY;
HEALTH CARE COST;
HEALTH CARE SYSTEM;
HUMAN;
HYPERTENSION;
ISCHEMIC HEART DISEASE;
MEDICAL SOCIETY;
META ANALYSIS;
MORTALITY;
PRACTICE GUIDELINE;
REVIEW;
AGING;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE DETERMINATION;
CANADA;
CARDIOVASCULAR DISEASES;
COST OF ILLNESS;
DIASTOLE;
GUIDELINES;
HUMANS;
HYPERTENSION;
PREVALENCE;
RISK FACTORS;
SYSTOLE;
|
EID: 0034491308
PISSN: 0828282X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (12)
|
References (21)
|